早期,低强度或标准强度连续脏置换治疗对酸控制和临床结果的影响:一项观察性研究
相关实验视频
Updated: Jun 23, 2025
05:34
5/6 Nephrectomy Using Sharp Bipolectomy Via Midline Laparotomy in Rats
Published on: April 4, 2025
548
Kosuke Yagi1, Tomoko Fujii1, Akira Kageyama2
1Intensive Care Unit, The Jikei University Hospital, Tokyo, Japan.
Blood purification
|June 16, 2024
概括
低强度连续置换疗法 (CRRT) 在急性损患者中有效纠正了酸平衡. 然而,与标准CRRT强度相比,这种方法在临床结果中没有显著差异.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 关键护理医学 关键护理医学
- 身体生理学 身体生理学
背景情况:
- 病改善全球结果 (KDIGO) 准则建议在急性损伤中使用20-25毫升/千克/小时的废水容量进行连续置换疗法 (CRRT).
- 新出现的证据表明,在CRRT启动期间减少干预强度可能会促进恢复.
- 本研究研究了早期低CRRT强度对酸平衡和临床结果的影响.
研究的目的:
- 探索早期低CRRT强度与酸平衡调整之间的关联.
- 评估CRRT强度对急性损伤重症患者临床结果的影响.
- 为了比较低强度CRRT与标准强度CRRT在处理酸干扰方面的有效性.
主要方法:
- 在第三级重症监护病房 (ICU) 进行了一项单中心,回顾性,观察性研究.
- 需要CRRT的成年患者被分为一个低组 (透析液流量[QD]10.0-19.9毫升/公斤/小时) 和一个标准组 (QD≥20毫升/公斤/小时).
- 用治疗权重分析的逆概率来评估CRRT强度组与结果之间的关联,重点关注酸参数在开始后6小时.
主要成果:
- 分析了194名患者:低组144名,标准组50名.
- 标准组表现出更严重的基线酸干扰 (较低的pH值和过多[BE]).
- 在CRRT启动6小时后,pH,BE和强离子差异在两组之间是可比的,即使调整了基线严重程度;临床结果没有显著差异.
结论:
- 标准强度CRRT在纠正早期酸失衡方面似乎有效.
- 低强度CRRT在酸校正中表现出可比的疗效,但临床结果没有明显的差异.
- 需要进一步的研究,以充分阐明不同CRRT强度的长期临床影响.
更多相关视频
相关概念视频
01:29Renal Regulation of Acid-Base Balance
399
Metabolic reactions in the body produce nonvolatile acids, such as sulfuric acid, which generate an acid load of approximately 1 mEq of H+ per kilogram of body weight daily. Excreting H+ in the urine is essential to balance this acid load.
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
In the kidneys, cells within the proximal convoluted tubules (PCT) and the collecting ducts secrete hydrogen ions (H+) into the tubular fluid. Specifically, in the PCT, Na+/H+ antiporters secrete H+ while reabsorbing Na+.
However, the intercalated cells in...
399
01:11Renal Failure: Dose Adjustments
80
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
80
01:17Factors Affecting Renal Clearance: Renal Impairment
81
Renal dysfunction significantly impairs the renal clearance of drugs, leading to potential complications in drug therapy. Renal failure, which can be caused by various factors, poses a significant challenge in the elimination of drugs from the body.
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...
81
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
420
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
420
01:22Renal Drug Excretion: Effect of Urine pH, Flow Rate, and Drug pKa
163
The pH of urine, the drug's pKa, and the urine flow rate are vital parameters for drug reabsorption and excretion. Urinary pH varies between 4.6 and 8.0 and is influenced by diet, drug intake, and the patient's pathophysiology. It affects a drug's ionization state and reabsorption. For instance, carbohydrate-rich food produces alkaline urine promoting drug excretion, while proteins and certain medications like ascorbic acid lead to acidic urine enhancing reabsorption.
The pKa of a...
The pKa of a...
163
01:27Dialysis
288
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
288